COWA LLC’s iShares Biotechnology ETF IBB Stock Holding History

COWA LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-140	Closed	-$34K	–	221
2021 Q1	$34K	Sell	140 -85	-38%	-$13.5K	0.02%	221
2020 Q4	$34K	Buy	+225	New	+$32.2K	0.03%	225

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

COWA LLC's IBB Position: Q2 2021 in Review

COWA LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 140 shares — an estimated $34K sold.

COWA LLC first reported a position in IBB in Q4 2020 and held it in 2 quarters. The position peaked at $34K in Q1 2021. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

COWA LLC reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
COWA LLC sold 140 iShares Biotechnology ETF shares in Q2 2021, an estimated $34K.
COWA LLC first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 2 quarters.
COWA LLC's iShares Biotechnology ETF position peaked at $34K in Q1 2021.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on COWA LLC's 13F filing for Q2 2021, filed 2 Aug 2021.